Clinical Trial Update: Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for AB001, an alpha radioligand therapy, in metastatic castration-resistant prostate cancer; the study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• AB001

Snippet

Sponsor: ARTBIO Inc. | Conditions: Prostate Cancer (CRPC), Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Phase 1 | Status: ACTIVE_NOT_RECRUITING